Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Imagine ... all the possibilities

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Mar 07, 2021 3:59pm

138 Views

Post# 32739672

RE:RE:RE:RE:RE:RE:Imagine ... all the possibilities

Beanie28 wrote:
how many shares and how many dollars have you lost from watching this thing go up and down? Have you ever see and bought back in on any of these high% swings

Good question ... bought at 20 cents ($2) in early 2017 ... bought big at 10 cents ($1) later in 2017 ... and then took as much as I could get at 8 cents ($0.80) on the further short-lived dip.

I do a little buying and selling - just to kill time but it's a small number of shares. I can't accumulate shares in a company if I'm playing the buy/sell game ... always end up with less shares that way.

<< Previous

Bullboard Posts

Next >>

Online behaviour puts Canadians at risk of cyberattacks, study finds